{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:45:52Z","timestamp":1785235552926,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.addbeh.2021.107143","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T19:13:07Z","timestamp":1634670787000},"page":"107143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications"],"prefix":"10.1016","volume":"125","author":[{"given":"J.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Montagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4010-5945","authenticated-orcid":false,"given":"T.","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Parhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2021.107143_b0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2015.01.055","article-title":"What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study","volume":"176","author":"Ambresin","year":"2015","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.addbeh.2021.107143_b0010","doi-asserted-by":"crossref","first-page":"e019491","DOI":"10.1136\/bmjopen-2017-019491","article-title":"Opioid prescribing for chronic musculoskeletal pain in UK primary care: Results from a cohort analysis of the COPERS trial","volume":"8","author":"Ashaye","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107143_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000497334","article-title":"Effects of treatment discontinuation in clinical psychopharmacology","volume":"88","author":"Baldessarini","year":"2019","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"October","key":"10.1016\/j.addbeh.2021.107143_b0020","first-page":"1","article-title":"Statins for primary prevention of cardiovascular disease","volume":"367","author":"Byrne","year":"2019","journal-title":"The BMJ"},{"issue":"6","key":"10.1016\/j.addbeh.2021.107143_b0025","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/add.14412","article-title":"Rising pregabalin use and misuse in Australia: Trends in utilization and intentional poisonings","volume":"114","author":"Cairns","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2021.107143_b0030","unstructured":"Conservatives. (2019). Health Secretary Matt Hancock\u2019s announcement of UK government commitment to implement a 24-hour helpline as a result of the PHE review: Conservatives News \u2018Launch a New Plan to Tackle Addiction\u2019 (28 Nov 2019). https:\/\/vote.conservatives.com\/news\/conservatives-to-launch-new-plan-to-tackle-addiction."},{"issue":"5","key":"10.1016\/j.addbeh.2021.107143_b0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and Persistent Withdrawal Syndromes following Discontinuation of Psychotropic Medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"7819","key":"10.1016\/j.addbeh.2021.107143_b0040","first-page":"1","article-title":"Antidepressant use and risk of adverse outcomes in older people: Population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ (Online)"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107143_b0045","first-page":"105","article-title":"Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care","volume":"5","author":"Cruickshank","year":"2008","journal-title":"Mental Health in Family Medicine"},{"key":"10.1016\/j.addbeh.2021.107143_b0050","unstructured":"Curtis, L. A., & Burns, A. (2019). Unit Costs of Health and Social Care 2019. Unit Costs of Health and Social Care. PSSRU, Kent, UK, 176 pp. ISBN 978-1-911353-10-2."},{"key":"10.1016\/j.addbeh.2021.107143_b0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.addbeh.2021.107143_b0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00213-002-1376-8","article-title":"Benzodiazepines: More \u201cbehaviourar\u201d addiction than dependence","volume":"167","author":"de Las Cuevas","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.addbeh.2021.107143_b0065","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1089\/jpm.2018.0149","article-title":"Opioid Medications in Expensive Formulations Are Sold at a Lower Price than Immediate-Release Morphine in Countries throughout the World: Third Phase of Opioid Price Watch Cross-Sectional Study","volume":"21","author":"de Lima","year":"2018","journal-title":"Journal of Palliative Medicine"},{"issue":"10","key":"10.1016\/j.addbeh.2021.107143_b0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1503\/cmaj.071068","article-title":"Selective serotonin reuptake inhibitors for unipolar depression: A systematic review of classic long-term randomized controlled trials","volume":"178","author":"Deshauer","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.addbeh.2021.107143_b0075","unstructured":"DHSC. (2021). Good for you, good for us, good for everybody. September. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1019475\/good-for-you-good-for-us-good-for-everybody.pdf#page32."},{"issue":"12","key":"10.1016\/j.addbeh.2021.107143_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17124500","article-title":"Advanced clinical practitioners in primary care in the UK: A qualitative study of workforce transformation","volume":"17","author":"Evans","year":"2020","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"4","key":"10.1016\/j.addbeh.2021.107143_b0085","first-page":"1","article-title":"Withdrawal of unnecessary antidepressant medication: A randomised controlled trial in primary care","volume":"1","author":"Eveleigh","year":"2017","journal-title":"BJGP Open"},{"key":"10.1016\/j.addbeh.2021.107143_b0090","unstructured":"Faculty of Pain Medicine. (n.d.). Faculty of Pain Medicine, Public Health England. Opioids Aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain. https:\/\/fpm.ac.uk\/opioids-aware-clinical-use-opioids\/opioids-long-term-pain."},{"key":"10.1016\/j.addbeh.2021.107143_b0095","first-page":"2019","article-title":"How much medicine is too much","volume":"364","author":"Godlee","year":"2019","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.addbeh.2021.107143_b0100","unstructured":"Group, P. C. (2021). Structured medication reviews and medicines optimisation: guidance. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/03\/B0431-network-contract-des-smr-and-mo-guidance-21-22.pdf."},{"issue":"1","key":"10.1016\/j.addbeh.2021.107143_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ijcp.12046","article-title":"Decreased acid suppression therapy overuse after education and medication reconciliation","volume":"67","author":"Gupta","year":"2013","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.addbeh.2021.107143_b0110","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320967183","article-title":"The \u2018patient voice\u2019: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition","volume":"10","author":"Guy","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/j.addbeh.2021.107143_b0115","unstructured":"Guy, A., & Davies, J. (2018). An Analysis of Four Current UK Service Models for Prescribed Medication Withdrawal Support: APPG for Prescribed Drug Dependence. http:\/\/prescribeddrug.org\/wp-content\/uploads\/2018\/11\/APPG-Service-Model-Report.pdf."},{"key":"10.1016\/j.addbeh.2021.107143_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320921694","article-title":"How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding","volume":"10","author":"Hengartner","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"528","key":"10.1016\/j.addbeh.2021.107143_b0125","first-page":"530","article-title":"Comparing the cost of nurse practitioners and GPs in primary care: Modelling economic data from randomized trials","volume":"56","author":"Hollinghurst","year":"2006","journal-title":"British Journal of General Practice"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107143_b0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12023","article-title":"Benzodiazepine dependence and its treatment with low dose flumazenil","volume":"77","author":"Hood","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.addbeh.2021.107143_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.106943","article-title":"Should gabapentinoids be prescribed long-term for anxiety and other mental health conditions?","volume":"119","author":"Horowitz","year":"2021","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.addbeh.2021.107143_b0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjmed.2012.10.027","article-title":"Effects of clinical pathways for common outpatient infections on antibiotic prescribing","volume":"126","author":"Jenkins","year":"2013","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107143_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-019-4036-y","article-title":"Patient consultation rate and clinical and NHS outcomes: A cross-sectional analysis of English primary care data from 2.7 million patients in 238 practices","volume":"19","author":"Lay-Flurrie","year":"2019","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.addbeh.2021.107143_b0150","doi-asserted-by":"crossref","unstructured":"Leeuwen, V., Ml, D., & Aim, D. S. (2021). Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (Review). 10.1002\/14651858.CD013495.pub2.www.cochranelibrary.com.","DOI":"10.1002\/14651858.CD013495.pub2"},{"issue":"8","key":"10.1016\/j.addbeh.2021.107143_b0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our Other Prescription Drug Problem","volume":"378","author":"Lembke","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107143_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz025","article-title":"Dependence, withdrawal and rebound of CNS drugs: An update and regulatory considerations for new drugs development","volume":"1","author":"Lerner","year":"2019","journal-title":"Brain Communications"},{"issue":"9","key":"10.1016\/j.addbeh.2021.107143_b0165","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/jgs.12427","article-title":"Gabapentin withdrawal: Case report in an older adult and review of the literature","volume":"61","author":"Mah","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"issue":"9","key":"10.1016\/j.addbeh.2021.107143_b0170","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-019-05069-5","article-title":"Measures Used to Assess the Impact of Interventions to Reduce Low-Value Care: A Systematic Review","volume":"34","author":"Maratt","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"April","key":"10.1016\/j.addbeh.2021.107143_b0175","first-page":"1","article-title":"Pregabalin and gabapentin for pain","volume":"369","author":"Mathieson","year":"2020","journal-title":"The BMJ"},{"issue":"3","key":"10.1016\/j.addbeh.2021.107143_b0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1060028015620800","article-title":"Gabapentin: Abuse, Dependence, and Withdrawal","volume":"50","author":"Mersfelder","year":"2016","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.addbeh.2021.107143_b0185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jval.2017.10.017","article-title":"A Framework for Measuring Low-Value Care","volume":"21","author":"Miller","year":"2018","journal-title":"Value in Health"},{"issue":"20","key":"10.1016\/j.addbeh.2021.107143_b0190","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.2018.12358","article-title":"Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993\u20132017","volume":"320","author":"Montastruc","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.addbeh.2021.107143_b0195","unstructured":"NICE. (n.d.). National Institute for Health and Care Excellence. British National Formulary. Hypnotics and Anxiolytics."},{"key":"10.1016\/j.addbeh.2021.107143_b0200","unstructured":"NICE. (2009). National Institute for Clinical Excellence. Depression in adults: Recognition and management. Clinical guideline [CG90]. London: NICE."},{"key":"10.1016\/j.addbeh.2021.107143_b0205","unstructured":"NICE. (2010). National Institute for Health and Care Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Technology appraisal guidance [TA77]. April 28, 2004. https:\/\/www.nice.org.uk\/guidance\/ta77."},{"key":"10.1016\/j.addbeh.2021.107143_b0210","unstructured":"NICE. (2021a). NICE. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (April 2021). https:\/\/www.nice.org.uk\/guidance\/ng193\/resources\/chronic-pain-primary-and-secondary-in-over-16s-assessment-of-all-chronic-pain-and-management-of-chronic-primary-pain-pdf-66142080468421."},{"key":"10.1016\/j.addbeh.2021.107143_b0215","unstructured":"NICE. (2021b). NICE. Controlled Drugs and Drug Dependence. 2021. https:\/\/bnf.nice.org.uk\/guidance\/controlled-drugs-and-drug-dependence.html#:~:text=Schedule 2 includes opiates (e.g.,for medicinal use in humans."},{"issue":"4","key":"10.1016\/j.addbeh.2021.107143_b0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002826-200107000-00011","article-title":"Gabapentin withdrawal syndrome","volume":"24","author":"Norton","year":"2001","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.addbeh.2021.107143_b0225","article-title":"OECD Health Statistics 2019","author":"OECD","year":"2019","journal-title":"StatLink"},{"issue":"5","key":"10.1016\/j.addbeh.2021.107143_b0230","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1097\/PR9.0000000000000840","article-title":"Long-term opioid therapy for chronic noncancer pain: Second update of the German guidelines","volume":"5","author":"Petzke","year":"2020","journal-title":"Pain Reports"},{"key":"10.1016\/j.addbeh.2021.107143_b0235","first-page":"1","article-title":"Antidepressant Use Among Persons Aged 12 and Over: United States, 2011\u20132014","volume":"283","author":"Pratt","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.addbeh.2021.107143_b0240","series-title":"Public Health England. Commissioning treatment for dependence on prescription and over-the-counter medicines: A guide for NHS and local authority commissioners","author":"Public Health England","year":"2013"},{"key":"10.1016\/j.addbeh.2021.107143_b0245","unstructured":"Public Health England. (2019). Dependence and withdrawal associated with some prescribed medicines An evidence review. 1\u2013152."},{"issue":"2","key":"10.1016\/j.addbeh.2021.107143_b0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000496734","article-title":"Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000\u20132017","volume":"88","author":"Recalt","year":"2019","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.addbeh.2021.107143_b0255","article-title":"Trends in long-term prescribing of dependence forming medicines","volume":"0819","author":"Sehmi","year":"2019","journal-title":"London: PHRC\/NatCen"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107143_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3122\/jabfm.2011.01.100121","article-title":"Prevalence, treatment, and control of depressive symptoms in the United States: Results from the National Health and Nutrition Examination Survey (NHANES), 2005\u20132008","volume":"24","author":"Shim","year":"2011","journal-title":"Journal of the American Board of Family Medicine"},{"issue":"4","key":"10.1016\/j.addbeh.2021.107143_b0265","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/fampra\/cmu019","article-title":"The monitoring of longer term prescriptions of antidepressants: Observational study in a primary care setting","volume":"31","author":"Sinclair","year":"2014","journal-title":"Family Practice"},{"key":"10.1016\/j.addbeh.2021.107143_b0270","first-page":"89","article-title":"Dependence and withdrawal associated with some prescribed medicines. An evidence review - technical annexe","author":"Taylor","year":"2019","journal-title":"Public Health England, London"},{"issue":"8","key":"10.1016\/j.addbeh.2021.107143_b0275","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.2017.21897","article-title":"Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts","volume":"319","author":"Wallach","year":"2018","journal-title":"JAMA - Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107143_b0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijcp.12182","article-title":"Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment","volume":"68","author":"Wettermark","year":"2014","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.addbeh.2021.107143_b0285","series-title":"Wide-ranging online data for epidemiologic research (WONDER)","author":"WONDER","year":"2020"},{"issue":"20","key":"10.1016\/j.addbeh.2021.107143_b0290","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1001\/jama.2016.3445","article-title":"Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006\u20132015","volume":"315","author":"Wong","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.addbeh.2021.107143_b0295","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","article-title":"Changes in trends and pattern of strong opioid prescribing in primary care","volume":"18","author":"Zin","year":"2014","journal-title":"European Journal of Pain (United Kingdom)"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:51:01Z","timestamp":1759690261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460321003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":59,"alternative-id":["S0306460321003282"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.107143","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.107143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107143"}}